Diphtheria is a major cause of morbidity and mortality in Indonesia. One estimate is that of every 5,000,000 children born in this country, approximately 29,000 (580 per 100,000) will develop the faucial form of the disease, and more than 5,000 (100 per 100,000) will die, giving an infection-to-death ratio of approximately 6:1 (12) . In Western countries, vaccination measures have reduced the yearly incidence to less than 0.07 per 100,000 and the infection-to-death ratio to 10:1 (3, 8) .
The major factor influencing infection and mortality rates is vaccination, and Indonesian public health authorities are attempting to lower the prevalence of the disease by including diphtheria vaccination in the Expanded Program on Immunization. Today, treatment is required for a large number of patients with this disease. Included in the treatment regimen is appropriate antimicrobial therapy to render Corynebacterium diphtheriae nonviable and thus stop toxin production that leads to associated complications. Erythromycin, tetracycline, clindamycin, and penicillin are considered the drugs of choice (9, 13) ; however, the emergence of C. diphtheriae resistant to erythromycin, clindamycin, and lincomycin has been reported (2, 6) . We found that a significant number of C. diphtheriae isolated from hospitalized diphtheria patients in Jakarta are resistant to tetracycline. Since this is a commonly used antibiotic in lieu of penicillin, clinicians should be aware that it may not be effective in treating diphtheria.
Nasopharyngeal-alginate swab specimens were collected from 181 suspected diphtheria patients in Cipto Mangunkusumo Hospital, Jakarta, Indonesia from October 1979 through June 1980. Cystine tellurite blood agar medium (14) was inoculated with the specimen and incubated 18 to 72 h at 37°C. Suspect C. diphtheriae colonies were subcultured to brain heart infusion agar, and the cultures were incubated 18 to 20 h at 37°C. Clones were tested for biochemical activity and biotype according to Herman and Bickham (5) and toxin production by a modified Elek procedure (1) with a diphtheria antitoxin (Bio Farma, Bandung, Indonesia).
The disk diffusion method (7) were sensitive to tetracycline by this method. The tetracycline minimal inhibitory concentration was 0.5 ,ug/ml for the same 19 C. diphtheriae isolates. The 114 remaining isolates were inhibited by 32 ,ug/ml (32%), 64 ,ug/ml (79%), or >128 ,g/ml (3%). The 19 sensitive strains were isolated from persons between 1 and 9 years old.
The tetracycline-resistant C. diphtheriae isolates (-32 p.g/ml) were interesting because of the reported sensitivity of C. diphtheriae to this antibiotic in other studies. Gordon et al. (4) Whether the resistance of our Indonesian isolates is due to plasmid or cellular involvement remains to be determined. The fact remains that a significant number of the isolates from children and adults were resistant to clinically unachievable levels of tetracycline, and this antimicrobial agent should no longer be considered as an alternative for the treatment of diphtheria in Jakarta. Fortunately, the bacterium appears to remain sensitive to penicillin and erythromycin. Further study and continued surveillance seems warranted to determine the type of resistance and whether C. diphtheriae develops resistance to these two antimicrobial agents in the future. This study was supported by funds from the Naval Research and Development Command, Navy Department for Work Unit MR-041.09-002-5037.
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